Get started
Author

Marianne Amalric

Observed names: AMALRIC, Marianne, Amalric, M, Amalric, Marianne, M AMALRIC, M Amalric, M. Amalric
Observed institutions: Université Paris-Sud, Scripps Research Institute, Centre National de la Recherche Scientifique, Scripps Health, Inserm, Université de Montpellier, Aix-Marseille Université, University of Cambridge, Laboratoire de Chimie et Biochimie Pharmacologiques et Toxicologiques, Institut de Biologie du Développement Marseille, Laboratoire de Neurosciences Cognitives, Laboratoire de Chimie, Scripps Clinic, Institut de Génomique Fonctionnelle, Université Paris Descartes, Université de la Méditerranée Aix-Marseille II, Université de Provence Aix-Marseille I, Centre de Recherche en Psychologie et Neurosciences
ORCID: 0000-0002-9915-6763
Observed ORCID: 0000-0002-9915-6763
OpenAlex ID: A5001475191
The neural substrates for the motor-activating properties of psychostimulants: A review of recent findings
1986 · Neal R. Swerdlow, Franco J. Vaccarino, et al. · Pharmacology Biochemistry and Behavior · 259
In a rat model of parkinsonism, lesions of the subthalamic nucleus reverse increases of reaction time but induce a dramatic premature responding deficit
1995 · C Baunez, A Nieoullon, et al. · Journal of Neuroscience · 255
PDF
The subthalamic nucleus exerts opposite control on cocaine and 'natural' rewards
2005 · Christelle Baunez, Carine Dias, et al. · Nature Neuroscience · 233
Depletion of dopamine in the caudate nucleus but not in nucleus accumbens impairs reaction-time performance in rats
1987 · M Amalric, GF Koob · Journal of Neuroscience · 198
PDF
Chronic But Not Acute Treatment with a Metabotropic Glutamate 5 Receptor Antagonist Reverses the Akinetic Deficits in a Rat Model of Parkinsonism
2002 · Nathalie Breysse, Christelle Baunez, et al. · Journal of Neuroscience · 182
PDF
Insight into the function of Group I and Group II metabotropic glutamate (mGlu) receptors: behavioural characterization and implications for the treatment of CNS disorders
2003 · W. Spooren, T. Ballard, et al. · Behavioural Pharmacology · 179
Enhanced Food-Related Motivation after Bilateral Lesions of the Subthalamic Nucleus
2002 · Christelle Baunez, Marianne Amalric, et al. · Journal of Neuroscience · 174
PDF
Chapter 14 Functionally selective neurochemical afferents and efferents of the mesocorticolimbic and nigrostriatal dopamine system
1993 · Marianne Amalric, George F. Koob · Progress in brain research · 142
Striatal Cholinergic Interneurons Control Motor Behavior and Basal Ganglia Function in Experimental Parkinsonism
2015 · Nicolas Maurice, Martine Liberge, et al. · Cell Reports · 135
PDF
Involvement of Striatal Cholinergic Interneurons and M1 and M4 Muscarinic Receptors in Motor Symptoms of Parkinson's Disease
2016 · S. Ztaou, N. Maurice, et al. · Journal of Neuroscience · 131
PDF
Electrophysiological and behavioral evidence that modulation of metabotropic glutamate receptor 4 with a new agonist reverses experimental parkinsonism
2009 · Corinne Beurrier, Sebastien Lopez, et al. · The FASEB Journal · 127
Rewarding properties of β-endorphin as measured by conditioned place preference
1987 · M. Amalric, E. J. Cline, et al. · Psychopharmacology · 125
Simultaneous Blockade of Adenosine A2A and Metabotropic Glutamate mGlu5 Receptors Increase their Efficacy in Reversing Parkinsonian Deficits in Rats
2004 · Roberto Coccurello, Nathalie Breysse, et al. · Neuropsychopharmacology · 122
Targeting Group III Metabotropic Glutamate Receptors Produces Complex Behavioral Effects in Rodent Models of Parkinson's Disease
2007 · S. Lopez, N. Turle-Lorenzo, et al. · Journal of Neuroscience · 110
PDF
The Metabotropic Glutamate Receptor 4-Positive Allosteric Modulator VU0364770 Produces Efficacy Alone and in Combination with l-DOPA or an Adenosine 2A Antagonist in Preclinical Rodent Models of Parkinson’s Disease
2011 · Carrie K. Jones, Michael Bubser, et al. · Journal of Pharmacology and Experimental Therapeutics · 108
High frequency stimulation of the subthalamic nucleus has beneficial antiparkinsonian effects on motor functions in rats, but less efficiency in a choice reaction time task
2003 · Yassine Darbaky, Claude Forni, et al. · European Journal of Neuroscience · 107
Complex Deficits on Reaction Time Performance following Bilateral Intrastriatal 6‐OHDA Infusion in the Rat
1995 · M. Amalric, H. Moukhles, et al. · European Journal of Neuroscience · 106
A novel selective metabotropic glutamate receptor 4 agonist reveals new possibilities for developing subtype selective ligands with therapeutic potential
2012 · Cyril Goudet, Bruno Vilar, et al. · The FASEB Journal · 105
Effects of dopamine D1 and D2 receptor blockade on MK-801-induced hyperlocomotion in rats
1993 · A. Ouagazzal, A. Nieoullon, et al. · Psychopharmacology · 103
Metabotropic Glutamate 5 Receptor Blockade Alleviates Akinesia by Normalizing Activity of Selective Basal-Ganglia Structures in Parkinsonian Rats
2003 · Nathalie Breysse, Marianne Amalric, et al. · Journal of Neuroscience · 99
PDF
Contribution of cholinergic interneurons to striatal pathophysiology in Parkinson's disease
2019 · Samira Ztaou, Marianne Amalric · Neurochemistry International · 89
PDF
Excitotoxic lesions of the prelimbic‐infralimbic areas of the rodent prefrontal cortex disrupt motor preparatory processes
2003 · Céline Risterucci, Denise Terramorsi, et al. · European Journal of Neuroscience · 88
Spatial deficits in a mouse model of Parkinson disease
2007 · Elvira De Leonibus, Tiziana Pascucci, et al. · Psychopharmacology · 86
Blockade of amphetamine but not opiate-induced locomotion following antagonism of dopamine function in the rat
1986 · Franco J. Vaccarino, Marianne Amalric, et al. · Pharmacology Biochemistry and Behavior · 82
Low doses of methylnaloxonium in the nucleus accumbens antagonize hyperactivity induced by heroin in the rat
1985 · M. Amalric, G.F. Koob · Pharmacology Biochemistry and Behavior · 80
Works count: 143
Citation count: 5,385
H-index: 41
I10-index: 75
Year
Topic
Type